Hepion Pharmaceuticals Stock (NASDAQ: HEPA) stock price, news, charts, stock research, profile.
Open | $1.370 |
Close | $1.365 |
Volume / Avg. | 9.146K / 78.367K |
Day Range | 1.330 - 1.410 |
52 Wk Range | 1.220 - 20.660 |
Market Cap | $7.388M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 1.15% |
Days to Cover | 2.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Hepion Pharmaceuticals (NASDAQ: HEPA) through any online brokerage.
Other companies in Hepion Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Palisade Bio (NASDAQ:PALI).
The latest price target for Hepion Pharmaceuticals (NASDAQ: HEPA) was reported by Brookline Capital on Thursday, December 7, 2023. The analyst firm set a price target for 0.00 expecting HEPA to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $1.35 last updated April 25, 2024 at 4:54 PM EDT.
There are no upcoming dividends for Hepion Pharmaceuticals.
Hepion Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Hepion Pharmaceuticals.
Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.